Arjun Kalra
Internal Medicine · Bethesda, MDNPI 1538624861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $590, more than ten times the $16 reported in 2021.
Across 53 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$264
- Sanofi$195
- Karyopharm Therapeutics Inc.$145
- Gilead$109
- Incyte Corporation$89
- Sobi, Inc$78
- plus $608 from 18 others
What the payments were for
- Food & beverage$1,487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $264 |
| Sanofi | 5 | $195 |
| Karyopharm Therapeutics Inc. | 6 | $145 |
| Gilead | 4 | $109 |
| Incyte Corporation | 4 | $89 |
| Sobi, Inc | 3 | $78 |
| Genmab U.S., Inc. | 2 | $66 |
| Exelixis Inc. | 2 | $64 |
| AstraZeneca | 3 | $57 |
| Beigene USA, Inc. | 2 | $55 |
| Mirati Therapeutics, Inc. | 2 | $54 |
| Recordati_rare_diseases_inc. | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Immunogen, Inc. | 1 | $23 |
| Morphosys, US Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $22 |
| BTG International Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclexta$124
How this compares
$1,487 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Bethesda
- Matthew MintzBethesda$135K
- Micaela IantornoBethesda$26K
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.